End of life decisions in immunocompromised patients with acute respiratory failure

Journal of Critical Care（2022）

引用 0|浏览15

暂无评分

摘要

•Decisions to forgo life-sustaining therapies (DFLSTs) are challenging.•We present a secondary analysis of the international EFRAIM prospective study.•A DFLST is made in one in four immunocompromised patient.•Patient-, disease- and organizational-related factors influence DFLSTs.•Involving a pulmonologist is associated with less non beneficial care.

查看译文

关键词

Decisions to forgo life-sustaining therapies,Hematological malignancies,Transplantation,Systemic diseases,Pneumocystis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要